< Back to Press

ASCENSIA DIABETES CARE COLLABORATES WITH SNAQ TO SUPPORT MEALTIME DECISION-MAKING FOR PEOPLE WITH DIABETES

Parsippany, United States

Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR^® Blood Glucose Monitoring (BGM) system portfolio and exclusive distributor of Eversense^® Continuous Glucose Monitoring (CGM) Systems, announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes (PWDs). Collaborating to integrate their technologies, Ascensia and SNAQ will empower more PWDs to make impactful mealtime decisions, with a goal to improve diabetes management.

Users of Ascensia’s world-renowned CONTOUR BGM portfolio will now be able to seamlessly incorporate SNAQ into their diabetes management regimen, in order to make data-driven decisions about food and nutrition. Through the SNAQ app, users simply take a photo of their food and are provided with nutritional information and actionable insights to help in facilitating glycemic control. With easy-to-read graphs and comparisons to previous meals, SNAQ supports both immediate insights and long-term learning, which is reflected in its strong user retention and high app ratings.

The initial three-year collaboration extends across several phases and regions, launching first in the United States. SNAQ will be integrated with Ascensia’s most popular Bluetooth connected BGM devices. SNAQ meal data can also be shared with GlucoContro.Online, Ascensia’s streamlined platform, which enables PWDs to seamlessly access, analyze and share their diabetes data. Making this data more easily accessible to PWDs and healthcare practitioners (HCPs) can help them to monitor how different foods affect blood glucose levels and adjust treatment accordingly.

Frank Held, Head of BGM Marketing and Strategy at Ascensia, commented: “This collaboration is a further step in Ascensia’s mission to simplify diabetes management whilst providing convenient and effective solutions for people with diabetes and their healthcare providers. I look forward to working together with SNAQ as we collaborate to bring this valuable tool to more people.”

Chester Lu, Head of BGM Digital Connected Solutions at Ascensia, added: “Many of the people we speak to with diabetes are looking for smart, connected technologies that give them the data they need when they need it. Data and technology have a central role in helping people to make treatment decisions, and our collaboration with SNAQ will ensure that insights to guide food and meal choice are easily found at the tap of an app.”

Aurelian Briner, CEO of SNAQ, commented: “Taking the guesswork out of mealtime glucose control is what SNAQ is aiming for, and this collaboration means that we will be able to support more people in their day-to-day choices. Working with Ascensia’s team is an exciting opportunity for SNAQ to grow and continue making a difference for people living with diabetes.”

PWDs and HCPs interested in learning more about SNAQ can visit www.ascensiadiabetes.com/snaq or download SNAQ at https://snaq.io/ascensia

Notes for Editors

About Ascensia Diabetes Care

Ascensia Diabetes Care is a global company focused entirely on helping people with diabetes. Our mission is to empower those living with diabetes through innovative solutions that simplify and improve their lives.

We are home to the world-renowned CONTOUR^® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense^® Continuous Glucose Monitoring Systems from Senseonics. These products combine advanced technology with user-friendly functionality to help people with diabetes manage their condition and make a positive difference to their lives. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.

Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation. Ascensia products are sold in more than 125 countries. Ascensia has around 1,500 employees and operations in 31 countries.

For further information, please visit the Ascensia Diabetes Care website at: http://www.ascensia.com

About PHC Holdings Corporation

PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia, and LSI Medience Corporation. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group’s consolidated net sales in FY2021 were JPY 340 billion with global distribution of products and services in more than 125 countries. www.phchd.com

About SNAQ

SNAQ supports people living with diabetes to take the guesswork out of mealtime decisions. The award-winning app helps to count the carbs, protein, and fat content of meals by snapping a photo and supports learning what keeps glucose levels in target range after meals. SNAQ connects to many popular diabetes devices and apps.

For further information, please visit the SNAQ website at: https://snaq.io

For more media enquiries, please contact:

Tim Stamper, Tim.Stamper@FTIConsulting.com